{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:20:07Z","timestamp":1759940407295},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,17]]},"DOI":"10.1093\/ajhp\/zxz057","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T09:10:14Z","timestamp":1558084214000},"page":"804-809","source":"Crossref","is-referenced-by-count":6,"title":["Two cases of severe neutropenia in patients on low-dose methotrexate and ceftriaxone"],"prefix":"10.1093","volume":"76","author":[{"given":"Rachel J","family":"Bubik","sequence":"first","affiliation":[{"name":"Mayo Clinic Department of Pharmacy, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas Ross","family":"Osmon","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Infectious Diseases, Mayo Clinic Department of Orthopedic Surgery, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin Patricia","family":"Oravec","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Infectious Diseases, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Grace","family":"Rivera","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Pharmacy, Rochester, MN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"2019051705094961900_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"2019051705094961900_CIT0002","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol Rev."},{"key":"2019051705094961900_CIT0003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrrheum.2011.171","article-title":"Perioperative care for patients with rheumatic diseases","volume":"8","author":"Akkara Veetil","year":"2011","journal-title":"Nat Rev Rheumatol."},{"key":"2019051705094961900_CIT0004","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CMR.00111-13","article-title":"Prosthetic joint infection","volume":"27","author":"Tande","year":"2014","journal-title":"Clin Microbiol Rev."},{"key":"2019051705094961900_CIT0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.60.3.214","article-title":"Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery","volume":"60","author":"Grennan","year":"2001","journal-title":"Ann Rheum Dis."},{"key":"2019051705094961900_CIT0006","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/acr.23274","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"2019051705094961900_CIT0007","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1634\/theoncologist.11-6-694","article-title":"Understanding and managing methotrexate nephrotoxicity","volume":"11","author":"Widemann","year":"2006","journal-title":"Oncologist."},{"key":"2019051705094961900_CIT0008","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1124\/jpet.102.034330","article-title":"Characterization of methotrexate transport and its drug interactions with human organic anion transporters","volume":"302","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther."},{"key":"2019051705094961900_CIT0009","first-page":"15","article-title":"Drug interactions with methotrexate","volume":"12","author":"Evans","year":"1985","journal-title":"J Rheumatol Suppl."},{"key":"2019051705094961900_CIT0010","first-page":"313858","article-title":"Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis","volume":"2013","author":"Patan\u00e8","year":"2013","journal-title":"Adv Pharmacol Sci."},{"key":"2019051705094961900_CIT0011","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/jac\/dku517","article-title":"Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists","volume":"70","author":"Gilchrist","year":"2015","journal-title":"J Antimicrob Chemother."},{"key":"2019051705094961900_CIT0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/1078155215608524","article-title":"Effect of ceftriaxone and cefepime on high-dose methotrexate clearance","volume":"22","author":"Tran","year":"2016","journal-title":"J Oncol Pharm Pract."},{"key":"2019051705094961900_CIT0013","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02897260","article-title":"Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits","volume":"26","author":"Iven","year":"1990","journal-title":"Cancer Chemother Pharmacol."},{"key":"2019051705094961900_CIT0014","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00264201","article-title":"The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits","volume":"21","author":"Iven","year":"1988","journal-title":"Cancer Chemother Pharmacol."},{"key":"2019051705094961900_CIT0015","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-081X(199804)19:3<163::AID-BDD82>3.0.CO;2-L","article-title":"The effects of non-steroidal anti-inflammatory drugs on the disposition of methotrexate in patients with rheumatoid arthritis","volume":"19","author":"Iqbal","year":"1998","journal-title":"Biopharm Drug Dispos."},{"key":"2019051705094961900_CIT0016","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/0091270005280100","article-title":"Coadministration of lansoprazole and naproxen does not affect the pharmacokinetic profile of methotrexate in adult patients with rheumatoid arthritis","volume":"45","author":"Vakily","year":"2005","journal-title":"J Clin Pharmacol."},{"key":"2019051705094961900_CIT0017","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3899\/jrheum.120345","article-title":"Safety of nonsteroidal antiinflammatory drugs and\/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review","volume":"90","author":"Colebatch","year":"2012","journal-title":"J Rheumatol Suppl."},{"key":"2019051705094961900_CIT0018","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther."},{"key":"2019051705094961900_CIT0019","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bmj.1.6120.1097","article-title":"Prolongation and enhancement of serum methotrexate concentrations by probenecid","volume":"1","author":"Aherne","year":"1978","journal-title":"Br Med J."},{"key":"2019051705094961900_CIT0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000238028","article-title":"Pharmacokinetics of rocephin, a highly active new cephalosporin with an exceptionally long biological half-life","volume":"27","author":"Stoeckel","year":"1981","journal-title":"Chemotherapy."},{"key":"2019051705094961900_CIT0021","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2165\/00003088-199630030-00002","article-title":"Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis","volume":"30","author":"Bannwarth","year":"1996","journal-title":"Clin Pharmacokinet."},{"key":"2019051705094961900_CIT0022","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncologist."},{"key":"2019051705094961900_CIT0023","doi-asserted-by":"crossref","first-page":"ofv007","DOI":"10.1093\/ofid\/ofv007","article-title":"Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature","volume":"2","author":"Uy","year":"2015","journal-title":"Open Forum Infect Dis."},{"key":"2019051705094961900_CIT0024","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jac\/dkl196","article-title":"Pharmacokinetic interaction between methotrexate and piperacillin\/tazobactam resulting in prolonged toxic concentrations of methotrexate","volume":"58","author":"Zarychanski","year":"2006","journal-title":"J Antimicrob Chemother."},{"key":"2019051705094961900_CIT0025","first-page":"1","article-title":"Anticancer Agents.","volume-title":"Applied pharmacokinetics: Principles of therapeutic drug monitoring","author":"Evans","year":"1992"},{"key":"2019051705094961900_CIT0026","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00003088-198510020-00001","article-title":"Clinical pharmacokinetics of the third generation cephalosporins","volume":"10","author":"Balant","year":"1985","journal-title":"Clin Pharmacokinet."},{"key":"2019051705094961900_CIT0027","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/0006-2952(90)90390-7","article-title":"Ceftriaxone binding to human serum albumin. Indirect displacement by probenecid and diazepam","volume":"40","author":"McNamara","year":"1990","journal-title":"Biochem Pharmacol."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/76\/11\/804\/28665439\/zxz057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,18]],"date-time":"2022-09-18T05:14:44Z","timestamp":1663478084000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/76\/11\/804\/5490794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,5,17]]},"published-print":{"date-parts":[[2019,5,17]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxz057","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,1]]},"published":{"date-parts":[[2019,5,17]]}}}